Formulation and Evaluation of a Screening Model for Submucosal Fibrosis Using Chingum with Dragon Fruit

Submucosal fibrosis (SMF) is a chronic, progressive oral disorder with malignant potential, commonly associated with areca nut chewing and other irritants. Early screening and preventive measures are vital to halt its progression. This study aims to formulate a functional chewing gum using Dragon fruit (Hylocereus undatus) extract, known for its antioxidant and anti-inflammatory properties, and evaluate its potential as a screening model for SMF. The chewing gum was prepared using standard excipients and evaluated for organoleptic properties, physicochemical parameters, in vitro release of antioxidants, and mucosal compatibility. Results showed effective incorporation of bioactive compounds from Dragon fruit, satisfactory chewing properties, and promising antioxidant release during simulated chewing. Preliminary tests indicated a potential role in supporting mucosal health and enhancing salivary biomarker responses linked to SMF. This study suggests that Dragon fruit-based chewing gum could serve as a novel, non-invasive adjunct for early screening and prevention of submucosal fibrosis. The Dragon fruit extract was obtained through maceration, standardized, and incorporated into a natural chingum matrix to form a mucoadhesive formulation. The prepared formulation was evaluated for its physicochemical properties, bioadhesive strength, spreadability, drug release behavior, and in vitro antioxidant and anti-fibrotic activity. Results indicated good mucoadhesive properties, sustained release of phytoconstituents, and significant inhibition of fibroblast proliferation and collagen synthesis in vitro. The incorporation of Dragon fruit enhances the therapeutic potential of the model by delivering bioactive compounds directly to the oral mucosa. This approach presents a promising tool for early screening and management of OSMF, particularly in resource-limited settings where non-invasive and cost-effective interventions are needed.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-02
DOI
https://doi.org/10.5281/zenodo.15577742
Primary Topic
Oral Health Pathology and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Formulation and Evaluation of a Screening Model for Submucosal Fibrosis Using Chingum with Dragon Fruit

Zenodo (CERN European Organization for Nuclear Research)
Oral Health Pathology and Treatment
article

Formulation and Evaluation of a Screening Model for Submucosal Fibrosis Using Chingum with Dragon Fruit

article en

Abstract

Submucosal fibrosis (SMF) is a chronic, progressive oral disorder with malignant potential, commonly associated with areca nut chewing and other irritants. Early screening and preventive measures are vital to halt its progression. This study aims to formulate a functional chewing gum using Dragon fruit (Hylocereus undatus) extract, known for its antioxidant and anti-inflammatory properties, and evaluate its potential as a screening model for SMF. The chewing gum was prepared using standard excipients and evaluated for organoleptic properties, physicochemical parameters, in vitro release of antioxidants, and mucosal compatibility. Results showed effective incorporation of bioactive compounds from Dragon fruit, satisfactory chewing properties, and promising antioxidant release during simulated chewing. Preliminary tests indicated a potential role in supporting mucosal health and enhancing salivary biomarker responses linked to SMF. This study suggests that Dragon fruit-based chewing gum could serve as a novel, non-invasive adjunct for early screening and prevention of submucosal fibrosis. The Dragon fruit extract was obtained through maceration, standardized, and incorporated into a natural chingum matrix to form a mucoadhesive formulation. The prepared formulation was evaluated for its physicochemical properties, bioadhesive strength, spreadability, drug release behavior, and in vitro antioxidant and anti-fibrotic activity. Results indicated good mucoadhesive properties, sustained release of phytoconstituents, and significant inhibition of fibroblast proliferation and collagen synthesis in vitro. The incorporation of Dragon fruit enhances the therapeutic potential of the model by delivering bioactive compounds directly to the oral mucosa. This approach presents a promising tool for early screening and management of OSMF, particularly in resource-limited settings where non-invasive and cost-effective interventions are needed.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 48%
Oral Health Pathology and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.